Companies: 10,795·Total market cap: $144.5T
Augmedix, Inc.

Augmedix, Inc.

AUGXNASDAQHealthcare
$2.35
$-0.01(-0.21%)
Market Cap$115908895
P/E Ratio
52W High$6.25
52W Low$0.73
Overview

Augmedix, Inc. (AUGX) Market Cap & Net Worth

Live market cap, enterprise value, and global rank — multi-year chart and annual table below.

augx · market cap & enterprise value · FMP · as of Oct 1, 2024

Core market cap & key metrics

As of Oct 1, 2024, Augmedix, Inc. (AUGX) has a market cap — also referred to as its net worth or valuation — of $115,908,895, making it one of the top most valuable companies globally. Market Cap = $2.35 × shares outstanding.

Market Cap (Net Worth)$115,908,895augx market cap 2026
Enterprise ValuemktCap + debt − cash
1-Year Changevs one year ago
Global Rankinglargest company by mkt cap
All-Time High$0augx highest market cap ever
Stock Price$2.35NASDAQ · Oct 1, 2024
How is Market Cap calculated?Market Cap = Stock Price × Shares Outstanding

About Market Cap, Net Worth & Valuation

Augmedix, Inc. (AUGX) has a market cap — also referred to as its net worth or valuation — of $115,908,895 as of Oct 1, 2024, making it the #0 most valuable company globally. Market Cap = Stock Price × Shares Outstanding.

Augmedix, Inc. reached its all-time high market cap of $0 on —. Comparing the Augmedix, Inc. market cap history illustrates one of the most extraordinary corporate growth stories.

Investors frequently compare Augmedix, Inc. net worth vs peers and ask how Augmedix, Inc. valuation compares to other countries. Its market cap reflects continued investor confidence.

Data: FMP · year-end market cap · not investment advice

Frequently Asked Questions

AUGX market cap · 6 questions

Augmedix, Inc.'s net worth — measured as market capitalization — is $115,908,895 as of Oct 1, 2024. It ranks #0 globally. Market Cap = $$2.35 (price) × shares outstanding.

AUGX net worth 2026market cap vs book valuelargest companies by market cap
Data: Financial Modeling Prep · Market cap updates daily · For informational purposes only, not investment advice.